Previous 10 | Next 10 |
home / stock / rhhby / rhhby news
2023-09-19 14:45:33 ET Summary Regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played a key role in the fight against COVID-19. Regeneron's revenue for the second quarter of 2023 was $3.16 billion, an increase of 10.5% compared to th...
2023-09-19 12:44:41 ET More on Scholar Rock Seeking Alpha’s Quant Rating on Scholar Rock Historical earnings data for Scholar Rock Financial information for Scholar Rock Scholar Rock: The Market Isn't Enthusiastic Despite Decent Clinical Data F...
2023-09-18 15:00:29 ET Summary Roche's stock price has declined, underperforming its peers, due to the loss of patent protection for its blockbuster drugs, lower Covid-related revenue and several pipeline setbacks. The company has developed second-generation drugs and expanded int...
2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...
2023-09-13 08:08:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The pharmaceutical industry is one of the most dynamic and innovative sectors in the world. It is constantly developing new drugs and treatments to address various health challenges and improve...
2023-09-09 08:26:31 ET Summary Alnylam has an upcoming FDA advisory committee meeting on the company's application for Onpattro in ATTR-CM, and I see some risk of a negative committee vote. Onpattro has met or exceeded the efficacy targets established with the FDA, but I expect th...
2023-09-08 15:00:57 ET More on the markets The Unemployment Rate Just Signaled That A Recession May Occur Within The Next 6 Months High Yield Signal Does Not Align With Bearish Outlook For SPY SPY: The Calm Before The Storm Bulls vs. Bears: SA analysts weigh ...
2023-09-08 08:45:53 ET Palm Beach, FL – September 8, 2023 – FinancialNewsMedia.com News Commentary – The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome (DES) or Dry E...
2023-09-07 21:05:27 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-09-07 08:25:18 ET More on Alnylam, Roche, etc. Alnylam: Unlimited Promise Or Unlimited Losses? Alnylam Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation Alnylam Pharmaceuticals, Inc. ( ALNY ) Q2 2023 Earnings Call Transcript Roche:...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Roche Holding Ltd ADR Website:
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety data were consistent with the known safety profile for Susvimo in people...